Related Experiment Video
Updated: Jul 11, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
[Epidemiology of Covid-19 and high blood pressure association at Mali'shospital]
Insights
High blood pressure patients hospitalized with COVID-19 (Coronavirus Disease 2019) showed significant mortality. Treatments included calcium channel blockers and renin-angiotensin-aldosterone system inhibitors, impacting disease prognosis.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Context:
- High blood pressure is a significant cardiovascular risk factor.
- Patients with cardiovascular risk factors face increased risk from COVID-19.
- Understanding the epidemiology of COVID-19 in hypertensive patients is crucial.
Purpose:
- To determine the epidemiology of COVID-19 infection in patients with high blood pressure.
- To analyze the characteristics and outcomes of hypertensive patients hospitalized with COVID-19.
Summary:
- A descriptive cross-sectional study in Bamako, Mali, analyzed 78 COVID-19 patients with hypertension.
- The mean age was 55.21 years, with a M/F sex ratio of 1.36.
- Hypertension was grade 2 in 37.2% and grade 3 in 3.8% of patients. Common symptoms included cough (41.02%). Treatments focused on calcium channel blockers and renin-angiotensin-aldosterone system inhibitors.
- Hospital mortality was 10.3%, with no significant difference between known and de novo hypertensive patients or by hypertension grade.
Impact:
- High blood pressure is associated with COVID-19, influencing disease prognosis.
- Treatment strategies involve calcium channel blockers and renin-angiotensin-aldosterone system inhibitors.
- The study highlights the significant mortality associated with hypertension in COVID-19 patients.
Introduction:
High blood pressure is a major cardiovascular risk factor. Patients with cardiovascular risk factors are at risk of developing COVID-19. The objective of this study was to determine epidemiology of Covid-19 infected in patients with high blood pressure.
Patients And Method:
Descriptive cross-sectional study from April 2020 to June 2020 about patients hospitalized for Covid 19 by PCR diagnosis at the Hopital du Mali Bamako and having high blood pressure. Admission registry and patient charts were used to collect data.
Results:
We collected 78 out of 484 in patients which mean hospital frequency of 16.11%. The mean age was 55.21 +/- 14.61 years. Sex ratio M / F was 1.36. Patients were followed for high blood pressure in 59% of cases. Medical history was ischemic heart disease in 2.6% and dilated cardiomyopathy in 2.6%. Main functional signs were cough in 41.02% and lost of taste in 11.53%. High blood pressure on admission was grade 2 in 37.2% and grade 3 in 3.8%. Treatments received were calcium channel blockers 41.02%, inhibitors of the reninangiotensinaldosterone system 16.66% and combinations 15.38%. Hospital mortality was 10.3%. There was no statistically significant difference in mortality between known hypertensive patients and de novo hypertensive patients. There was also no statistically significant difference in mortality by grade of hypertension.
Conclusion:
High blood pressure can be associated to Covid 19. Treatment is based on calcium channel blockers and reninangiotensinaldosterone system inhibitors. It has an impact on the prognosis of the disease with significant mortality.
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Errors occurring during blood pressure monitoring
Several factors...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction

